Vijaya Diagnostic Centre Limited
Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. The company offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine and PET/CT, and MRI-3T services. It also provides health checkups and home sample collection services. Vijaya Diagnostic Centre Limited was founded in 1981 and is based in Hyderabad, India.
Valuation
Profitability
Returns
Solvency
AI Summary
Indian StockStrengths1
- Healthy return on equity of 17.6%
Concerns1
- Negative free cash flow (βΉ6 Cr)
Rule-based from financial data. Not advice.
Monthly Returns
Year-to-Date ROI
Historical Volatility
Historical Performance
Revenue, profitability, and cash flow trends (βΉ Crores)
Revenue (10Y)
Operating Income (10Y)
Net Profit (10Y)
Operating Margin % (10Y)
Dividend Payout % (10Y)
Free Cash Flow (10Y)
Growth Summary
Latest fiscal year: Mar 2025
Historical Growth
Year-by-year revenue, profitability, and cash flow (βΉ Crores, last 8 years)
| Year | Revenue | Op. Income | Net Profit | CFO | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|---|
| Mar 2025 | βΉ627.00 Cr | β | βΉ135.00 Cr | β | β | 17.2% | 19.4% | 17.4% |
| Mar 2024 | βΉ525.00 Cr | β | βΉ115.00 Cr | β | β | 17.6% | 16.7% | 38.6% |
| Mar 2023 | βΉ450.00 Cr | β | βΉ83.00 Cr | β | β | 15.2% | -0.2% | -23.1% |
| Mar 2022 | βΉ451.00 Cr | β | βΉ108.00 Cr | β | β | 23.0% | 22.9% | 30.1% |
| Mar 2021 | βΉ367.00 Cr | β | βΉ83.00 Cr | β | β | 23.0% | 11.6% | 36.1% |
| Mar 2020 | βΉ329.00 Cr | β | βΉ61.00 Cr | β | β | 21.9% | 17.9% | 24.5% |
| Mar 2019 | βΉ279.00 Cr | β | βΉ49.00 Cr | β | β | 22.7% | 17.2% | 40.0% |
| Mar 2018 | βΉ238.00 Cr | β | βΉ35.00 Cr | β | β | 21.0% | β | β |
Financial Statements
Income statement, balance sheet, and cash flow (βΉ Crores, as reported)
Consolidated Figures in USD Millions.
| Unnamed: 0 | TTM |
|---|---|
| Revenue / Net Sales | 682 |
| Total Expenses | 407 |
| EBIT / Operating Profit | 275 |
| OPM % | 40% |
| Other Income | 22 |
| Finance Costs | 27 |
| Depreciation & Amortisation | 72 |
| Profit Before Tax | 199 |
| Tax % | - |
| Net Profit / PAT | 148 |
| EPS (βΉ) | 14.43 |
| Dividend Payout % | - |
Peer Comparison
Healthcare sector peers, ranked by market cap
| Company | Market Cap | Revenue | P/E | P/B | EV/EBITDA | Rev G 1Y |
|---|---|---|---|---|---|---|
| Vijaya Diagnostic Centre Limitedthis co. | βΉ10.30 K Cr | βΉ627.00 Cr | 69.20 | 12.14 | 45.56 | 19.4% |
| Sun Pharmaceutical Industries Ltd. | βΉ4.15 L Cr | βΉ23.00 K Cr | 88.70 | 17.43 | 72.30 | 13.5% |
| Divi's Laboratories Ltd. | βΉ1.71 L Cr | βΉ9.20 K Cr | 67.90 | 11.13 | 67.21 | 20.0% |
| Torrent Pharmaceuticals Ltd. | βΉ1.33 L Cr | βΉ9.68 K Cr | 62.50 | 15.76 | 45.64 | 13.5% |
| Cipla Ltd. | βΉ1.17 L Cr | βΉ19.05 K Cr | 22.50 | 3.51 | 19.33 | 14.9% |
| Apollo Hospitals Enterprises Ltd. | βΉ1.05 L Cr | βΉ8.20 K Cr | 75.00 | 11.28 | 54.44 | 12.8% |
| Max Healthcare Institute Limited | βΉ1.00 L Cr | βΉ2.66 K Cr | 144.00 | 11.76 | 96.84 | 13.8% |
| Industry Average | β | βΉ3.29 K Cr | 98.63 | 8.11 | 65.50 | 20.2% |